Published in Sensors (Basel) on July 04, 2008
Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine. J Neural Transm (Vienna) (2016) 0.75
Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev (1999) 6.26
Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67
Structure and function of the brain serotonin system. Physiol Rev (1992) 5.30
The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull (1983) 5.23
DARPP-32: an integrator of neurotransmission. Annu Rev Pharmacol Toxicol (2004) 3.84
Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol (2008) 2.83
Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking. Neuron (2004) 2.57
The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour. Nat Rev Neurosci (2004) 2.53
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci (2006) 2.29
Thigmotaxis as an index of anxiety in mice. Influence of dopaminergic transmissions. Behav Brain Res (1994) 2.20
Adenosine A2A receptors and basal ganglia physiology. Prog Neurobiol (2007) 1.90
The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci (1997) 1.84
Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacol Biochem Behav (1986) 1.56
Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats. J Neurochem (1997) 1.51
Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J Neurosci (2002) 1.21
Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci (2002) 1.20
Caffeine--an atypical drug of dependence. Drug Alcohol Depend (1998) 1.19
Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem (2006) 1.19
Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma. Psychopharmacology (Berl) (2003) 1.16
Neuronal Gq/11-coupled dopamine receptors: an uncharted role for dopamine. Trends Pharmacol Sci (2007) 1.16
Gender differences in response to intranasal cocaine administration to humans. Biol Psychiatry (1996) 1.13
Regulation of psychostimulant-induced signaling and gene expression in the striatum. J Neurochem (2008) 1.07
G-protein-coupled receptor heteromers: function and ligand pharmacology. Br J Pharmacol (2007) 1.07
Chronic but not acute treatment with caffeine attenuates traumatic brain injury in the mouse cortical impact model. Neuroscience (2007) 1.04
Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats. Psychopharmacology (Berl) (2005) 1.03
Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci (2006) 1.03
Repeated cocaine administration changes the function and subcellular distribution of adenosine A1 receptor in the rat nucleus accumbens. J Neurochem (2003) 1.00
A dopaminergic deficit hypothesis of schizophrenia: the path to discovery. Dialogues Clin Neurosci (2006) 0.99
Sex differences in cocaine-induced behavioral sensitization. Cell Mol Biol (Noisy-le-grand) (2001) 0.98
Rats with persistently low or high exploratory activity: behaviour in tests of anxiety and depression, and extracellular levels of dopamine. Behav Brain Res (2006) 0.97
Involvement of adenosine A2A and dopamine receptors in the locomotor and sensitizing effects of cocaine. Brain Res (2006) 0.97
Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats. J Pharmacol Exp Ther (2001) 0.96
Effect of the selective 5-HT2 antagonist ketanserin on adenosine-induced bronchoconstriction in asthmatic subjects. Immunopharmacology (1992) 0.94
Heterodimeric adenosine receptors: a device to regulate neurotransmitter release. Cell Mol Life Sci (2006) 0.94
Caffeine exposure sensitizes rats to the reinforcing effects of cocaine. Neuroreport (1991) 0.90
Effects of prenatal exposure to cocaine on the developing brain: anatomical, chemical, physiological and behavioral consequences. Neurotox Res (2001) 0.88
Cocaine-induced reinstatement in rats: evidence for a critical role of cocaine stimulus properties. Psychopharmacology (Berl) (2008) 0.88
Dietary additives and the acquisition of cocaine self-administration in rats. Psychopharmacology (Berl) (1998) 0.88
Up-regulation of dopamine receptors in the brain of the spontaneously hypertensive rat: an autoradiographic analysis. Neuroscience (1993) 0.87
Increase in A2A receptors in the nucleus accumbens after extended cocaine self-administration and its disappearance after cocaine withdrawal. Brain Res (2007) 0.87
The adenosine receptor antagonist CGS15943 reinstates cocaine-seeking behavior and maintains self-administration in baboons. Psychopharmacology (Berl) (2003) 0.85
Monoamine neurotransmitters in resected hippocampal subparcellations from neocortical and mesial temporal lobe epilepsy patients: in situ microvoltammetric studies. Brain Res (2000) 0.84
In vivo electrochemical studies of dopamine clearance in subregions of rat nucleus accumbens: differential properties of the core and shell. Exp Neurol (1998) 0.84
I. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT--DA interaction in cocaine dysfunctional behavior. Neurosci Biobehav Rev (1997) 0.84
Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors. J Pharmacol Exp Ther (2007) 0.83
Real time detection of acute (IP) cocaine-enhanced dopamine and serotonin release in ventrolateral nucleus accumbens of the behaving Norway rat. Pharmacol Biochem Behav (1993) 0.83
Characterizing stearate probes in vitro for the electrochemical detection of dopamine and serotonin. Brain Res (1989) 0.82
Distinguishing in vitro electrochemical signatures for norepinephrine and dopamine. Neurosci Lett (1988) 0.82
Cocaine and cardiovascular toxicity. Addict Biol (1996) 0.82
Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.82
Comparative study of sinoaortic denervated rats and spontaneously hypertensive rats. Am J Hypertens (2003) 0.82
Light microscopic immunocytochemical evidence of converging serotonin and dopamine terminals in ventrolateral nucleus accumbens. Brain Res Bull (1995) 0.82
Distinctions between dopamine transporter antagonists could be just around the bend. Mol Pharmacol (2007) 0.81
Acute and repeated exposure to caffeine: effects on reinstatement of extinguished cocaine-taking behavior in rats. Psychopharmacology (Berl) (1996) 0.81
Major differences in the behaviour of carbon paste and carbon fibre electrodes in a protein-lipid matrix: implications for voltammetry in vivo. Analyst (1998) 0.81
In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain. J Neurosci Res (2000) 0.81
Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.81
Cholecystokinin-induced release of dopamine in the nucleus accumbens of the spontaneously hypertensive rat. Brain Res (1995) 0.80
Studies of oxidative stress mechanisms using a morphine / ascorbate animal model and novel N-stearoyl cerebroside and laurate sensors. J Neural Transm (Vienna) (2007) 0.80
Novel research translates to clinical cases of schizophrenic and cocaine psychosis. Neuropsychiatr Dis Treat (2007) 0.78
Serotonin-induced platelet aggregation predicts the antihypertensive response to serotonin receptor antagonists. Eur J Clin Pharmacol (1993) 0.77
In vivo autoradiography of [3H]SCH 39166 in rat brain: selective displacement by D1/D5 antagonists. J Chem Neuroanat (2000) 0.77
Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration. Neuroscience (1999) 0.77
The alpha-adrenergic receptor blocking effect of ketanserin and the interaction between alpha-adrenergic and S2-serotonergic receptor blockade. J Cardiovasc Pharmacol (1988) 0.76
Muscarinic cholinergic and beta-adrenergic contribution to hindquarters vasodilation and cardiac responses to cocaine. J Pharmacol Exp Ther (2003) 0.76
Effect of serotonergic agents on adenosine A2 receptor mediated catalepsy in mice. Psychopharmacology (Berl) (1998) 0.76
Applications of modified electrodes in the voltammetric determination of catecholamine neurotransmitters. Biotechnology (1989) 0.76